nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—lung cancer	0.168	1	CbGaD
Pethidine—ORM1—Gefitinib—lung cancer	0.101	0.187	CbGbCtD
Pethidine—ORM1—Erlotinib—lung cancer	0.0595	0.111	CbGbCtD
Pethidine—ALB—Gefitinib—lung cancer	0.0423	0.0787	CbGbCtD
Pethidine—CYP2C19—Gefitinib—lung cancer	0.0275	0.051	CbGbCtD
Pethidine—CYP2C19—Teniposide—lung cancer	0.0266	0.0495	CbGbCtD
Pethidine—ALB—Erlotinib—lung cancer	0.025	0.0465	CbGbCtD
Pethidine—CYP2B6—Irinotecan—lung cancer	0.0231	0.0429	CbGbCtD
Pethidine—ALB—Irinotecan—lung cancer	0.0226	0.042	CbGbCtD
Pethidine—CYP2D6—Gefitinib—lung cancer	0.0209	0.0388	CbGbCtD
Pethidine—CYP2B6—Cisplatin—lung cancer	0.0188	0.0349	CbGbCtD
Pethidine—CYP2D6—Vinorelbine—lung cancer	0.0161	0.0299	CbGbCtD
Pethidine—CYP3A4—Topotecan—lung cancer	0.0145	0.027	CbGbCtD
Pethidine—CYP3A4—Gefitinib—lung cancer	0.0133	0.0247	CbGbCtD
Pethidine—CYP3A4—Teniposide—lung cancer	0.0129	0.0239	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—lung cancer	0.0126	0.0234	CbGbCtD
Pethidine—CYP2D6—Erlotinib—lung cancer	0.0123	0.0229	CbGbCtD
Pethidine—ALB—Methotrexate—lung cancer	0.012	0.0222	CbGbCtD
Pethidine—CYP3A4—Vinorelbine—lung cancer	0.0102	0.019	CbGbCtD
Pethidine—CYP2D6—Vinblastine—lung cancer	0.00991	0.0184	CbGbCtD
Pethidine—CYP3A4—Crizotinib—lung cancer	0.00813	0.0151	CbGbCtD
Pethidine—CYP3A4—Erlotinib—lung cancer	0.00785	0.0146	CbGbCtD
Pethidine—CYP3A4—Paclitaxel—lung cancer	0.00718	0.0133	CbGbCtD
Pethidine—CYP3A4—Irinotecan—lung cancer	0.00709	0.0132	CbGbCtD
Pethidine—CYP3A4—Vinblastine—lung cancer	0.0063	0.0117	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—lung cancer	0.00609	0.0113	CbGbCtD
Pethidine—CYP3A4—Etoposide—lung cancer	0.00568	0.0105	CbGbCtD
Pethidine—CYP3A4—Docetaxel—lung cancer	0.00519	0.00965	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—lung cancer	0.00387	0.00719	CbGbCtD
Pethidine—Hypersensitivity—Topotecan—lung cancer	0.000245	0.00175	CcSEcCtD
Pethidine—Tremor—Cisplatin—lung cancer	0.000244	0.00175	CcSEcCtD
Pethidine—Constipation—Vinorelbine—lung cancer	0.000243	0.00174	CcSEcCtD
Pethidine—Hypertension—Gemcitabine—lung cancer	0.000242	0.00173	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—lung cancer	0.000239	0.00171	CcSEcCtD
Pethidine—Asthenia—Topotecan—lung cancer	0.000238	0.0017	CcSEcCtD
Pethidine—Confusional state—Irinotecan—lung cancer	0.000236	0.00169	CcSEcCtD
Pethidine—Asthenia—Erlotinib—lung cancer	0.000236	0.00168	CcSEcCtD
Pethidine—Pruritus—Topotecan—lung cancer	0.000235	0.00168	CcSEcCtD
Pethidine—Anaphylactic shock—Irinotecan—lung cancer	0.000234	0.00167	CcSEcCtD
Pethidine—Oedema—Irinotecan—lung cancer	0.000234	0.00167	CcSEcCtD
Pethidine—Erythema—Paclitaxel—lung cancer	0.000234	0.00167	CcSEcCtD
Pethidine—Feeling abnormal—Vinorelbine—lung cancer	0.000234	0.00167	CcSEcCtD
Pethidine—Pruritus—Erlotinib—lung cancer	0.000233	0.00166	CcSEcCtD
Pethidine—Shock—Irinotecan—lung cancer	0.000231	0.00165	CcSEcCtD
Pethidine—Muscle spasms—Etoposide—lung cancer	0.00023	0.00164	CcSEcCtD
Pethidine—Oedema—Gemcitabine—lung cancer	0.000228	0.00163	CcSEcCtD
Pethidine—Anaphylactic shock—Gemcitabine—lung cancer	0.000228	0.00163	CcSEcCtD
Pethidine—Irritability—Methotrexate—lung cancer	0.000227	0.00162	CcSEcCtD
Pethidine—Hyperhidrosis—Irinotecan—lung cancer	0.000227	0.00162	CcSEcCtD
Pethidine—Dizziness—Vinblastine—lung cancer	0.000226	0.00162	CcSEcCtD
Pethidine—Convulsion—Cisplatin—lung cancer	0.000226	0.00161	CcSEcCtD
Pethidine—Urticaria—Vinorelbine—lung cancer	0.000226	0.00161	CcSEcCtD
Pethidine—Muscle spasms—Paclitaxel—lung cancer	0.000225	0.00161	CcSEcCtD
Pethidine—Mood swings—Methotrexate—lung cancer	0.000225	0.00161	CcSEcCtD
Pethidine—Anorexia—Irinotecan—lung cancer	0.000223	0.0016	CcSEcCtD
Pethidine—Anxiety—Cisplatin—lung cancer	0.000221	0.00158	CcSEcCtD
Pethidine—Hyperhidrosis—Gemcitabine—lung cancer	0.000221	0.00158	CcSEcCtD
Pethidine—Visual impairment—Docetaxel—lung cancer	0.00022	0.00157	CcSEcCtD
Pethidine—Dizziness—Topotecan—lung cancer	0.00022	0.00157	CcSEcCtD
Pethidine—Tremor—Paclitaxel—lung cancer	0.000219	0.00157	CcSEcCtD
Pethidine—Hypotension—Irinotecan—lung cancer	0.000219	0.00156	CcSEcCtD
Pethidine—Anorexia—Gemcitabine—lung cancer	0.000218	0.00155	CcSEcCtD
Pethidine—Vomiting—Vinblastine—lung cancer	0.000217	0.00155	CcSEcCtD
Pethidine—Dizziness—Erlotinib—lung cancer	0.000217	0.00155	CcSEcCtD
Pethidine—Agitation—Paclitaxel—lung cancer	0.000215	0.00154	CcSEcCtD
Pethidine—Vertigo—Etoposide—lung cancer	0.000215	0.00153	CcSEcCtD
Pethidine—Headache—Vinblastine—lung cancer	0.000214	0.00153	CcSEcCtD
Pethidine—Hypotension—Gemcitabine—lung cancer	0.000213	0.00152	CcSEcCtD
Pethidine—Anaphylactic shock—Cisplatin—lung cancer	0.000213	0.00152	CcSEcCtD
Pethidine—Oedema—Cisplatin—lung cancer	0.000213	0.00152	CcSEcCtD
Pethidine—Insomnia—Irinotecan—lung cancer	0.000212	0.00151	CcSEcCtD
Pethidine—Flushing—Docetaxel—lung cancer	0.000212	0.00151	CcSEcCtD
Pethidine—Vomiting—Topotecan—lung cancer	0.000211	0.00151	CcSEcCtD
Pethidine—Vertigo—Paclitaxel—lung cancer	0.00021	0.0015	CcSEcCtD
Pethidine—Syncope—Paclitaxel—lung cancer	0.00021	0.0015	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—lung cancer	0.00021	0.0015	CcSEcCtD
Pethidine—Rash—Topotecan—lung cancer	0.00021	0.0015	CcSEcCtD
Pethidine—Hypersensitivity—Vinorelbine—lung cancer	0.000209	0.0015	CcSEcCtD
Pethidine—Dermatitis—Topotecan—lung cancer	0.000209	0.0015	CcSEcCtD
Pethidine—Vomiting—Erlotinib—lung cancer	0.000209	0.00149	CcSEcCtD
Pethidine—Somnolence—Irinotecan—lung cancer	0.000208	0.00149	CcSEcCtD
Pethidine—Headache—Topotecan—lung cancer	0.000208	0.00149	CcSEcCtD
Pethidine—Tachycardia—Cisplatin—lung cancer	0.000208	0.00148	CcSEcCtD
Pethidine—Rash—Erlotinib—lung cancer	0.000207	0.00148	CcSEcCtD
Pethidine—Dermatitis—Erlotinib—lung cancer	0.000207	0.00148	CcSEcCtD
Pethidine—Palpitations—Paclitaxel—lung cancer	0.000207	0.00148	CcSEcCtD
Pethidine—Convulsion—Etoposide—lung cancer	0.000207	0.00148	CcSEcCtD
Pethidine—Insomnia—Gemcitabine—lung cancer	0.000207	0.00148	CcSEcCtD
Pethidine—Hypertension—Etoposide—lung cancer	0.000206	0.00147	CcSEcCtD
Pethidine—Headache—Erlotinib—lung cancer	0.000206	0.00147	CcSEcCtD
Pethidine—Loss of consciousness—Paclitaxel—lung cancer	0.000206	0.00147	CcSEcCtD
Pethidine—Hyperhidrosis—Cisplatin—lung cancer	0.000206	0.00147	CcSEcCtD
Pethidine—Asthenia—Vinorelbine—lung cancer	0.000204	0.00146	CcSEcCtD
Pethidine—Decreased appetite—Irinotecan—lung cancer	0.000204	0.00146	CcSEcCtD
Pethidine—Nausea—Vinblastine—lung cancer	0.000203	0.00145	CcSEcCtD
Pethidine—Somnolence—Gemcitabine—lung cancer	0.000203	0.00145	CcSEcCtD
Pethidine—Convulsion—Paclitaxel—lung cancer	0.000203	0.00145	CcSEcCtD
Pethidine—Anorexia—Cisplatin—lung cancer	0.000203	0.00145	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—lung cancer	0.000203	0.00145	CcSEcCtD
Pethidine—Hypertension—Paclitaxel—lung cancer	0.000202	0.00144	CcSEcCtD
Pethidine—Pruritus—Vinorelbine—lung cancer	0.000201	0.00144	CcSEcCtD
Pethidine—Constipation—Irinotecan—lung cancer	0.0002	0.00143	CcSEcCtD
Pethidine—Hypotension—Cisplatin—lung cancer	0.000199	0.00142	CcSEcCtD
Pethidine—Anxiety—Paclitaxel—lung cancer	0.000199	0.00142	CcSEcCtD
Pethidine—Erythema—Docetaxel—lung cancer	0.000199	0.00142	CcSEcCtD
Pethidine—Decreased appetite—Gemcitabine—lung cancer	0.000199	0.00142	CcSEcCtD
Pethidine—Nausea—Topotecan—lung cancer	0.000197	0.00141	CcSEcCtD
Pethidine—Confusional state—Etoposide—lung cancer	0.000197	0.0014	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—lung cancer	0.000196	0.0014	CcSEcCtD
Pethidine—Constipation—Gemcitabine—lung cancer	0.000195	0.00139	CcSEcCtD
Pethidine—Nausea—Erlotinib—lung cancer	0.000195	0.00139	CcSEcCtD
Pethidine—Dry mouth—Paclitaxel—lung cancer	0.000195	0.00139	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—lung cancer	0.000195	0.00139	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—lung cancer	0.000195	0.00139	CcSEcCtD
Pethidine—Feeling abnormal—Irinotecan—lung cancer	0.000193	0.00138	CcSEcCtD
Pethidine—Confusional state—Paclitaxel—lung cancer	0.000193	0.00138	CcSEcCtD
Pethidine—Anaphylactic shock—Paclitaxel—lung cancer	0.000191	0.00137	CcSEcCtD
Pethidine—Oedema—Paclitaxel—lung cancer	0.000191	0.00137	CcSEcCtD
Pethidine—Muscle spasms—Docetaxel—lung cancer	0.000191	0.00136	CcSEcCtD
Pethidine—Tachycardia—Etoposide—lung cancer	0.00019	0.00136	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—lung cancer	0.000189	0.00135	CcSEcCtD
Pethidine—Feeling abnormal—Gemcitabine—lung cancer	0.000188	0.00134	CcSEcCtD
Pethidine—Shock—Paclitaxel—lung cancer	0.000188	0.00134	CcSEcCtD
Pethidine—Dizziness—Vinorelbine—lung cancer	0.000188	0.00134	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000188	0.00134	CcSEcCtD
Pethidine—Tachycardia—Paclitaxel—lung cancer	0.000187	0.00133	CcSEcCtD
Pethidine—Anorexia—Etoposide—lung cancer	0.000186	0.00133	CcSEcCtD
Pethidine—Decreased appetite—Cisplatin—lung cancer	0.000185	0.00132	CcSEcCtD
Pethidine—Hyperhidrosis—Paclitaxel—lung cancer	0.000185	0.00132	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—lung cancer	0.000183	0.00131	CcSEcCtD
Pethidine—Anorexia—Paclitaxel—lung cancer	0.000182	0.0013	CcSEcCtD
Pethidine—Hypotension—Etoposide—lung cancer	0.000182	0.0013	CcSEcCtD
Pethidine—Vomiting—Vinorelbine—lung cancer	0.000181	0.00129	CcSEcCtD
Pethidine—Rash—Vinorelbine—lung cancer	0.000179	0.00128	CcSEcCtD
Pethidine—Dermatitis—Vinorelbine—lung cancer	0.000179	0.00128	CcSEcCtD
Pethidine—Hypotension—Paclitaxel—lung cancer	0.000179	0.00128	CcSEcCtD
Pethidine—Headache—Vinorelbine—lung cancer	0.000178	0.00127	CcSEcCtD
Pethidine—Syncope—Docetaxel—lung cancer	0.000178	0.00127	CcSEcCtD
Pethidine—Sweating—Methotrexate—lung cancer	0.000176	0.00125	CcSEcCtD
Pethidine—Palpitations—Docetaxel—lung cancer	0.000175	0.00125	CcSEcCtD
Pethidine—Feeling abnormal—Cisplatin—lung cancer	0.000175	0.00125	CcSEcCtD
Pethidine—Loss of consciousness—Docetaxel—lung cancer	0.000175	0.00125	CcSEcCtD
Pethidine—Somnolence—Etoposide—lung cancer	0.000173	0.00124	CcSEcCtD
Pethidine—Insomnia—Paclitaxel—lung cancer	0.000173	0.00124	CcSEcCtD
Pethidine—Hypersensitivity—Irinotecan—lung cancer	0.000173	0.00123	CcSEcCtD
Pethidine—Convulsion—Docetaxel—lung cancer	0.000172	0.00123	CcSEcCtD
Pethidine—Hypertension—Docetaxel—lung cancer	0.000171	0.00122	CcSEcCtD
Pethidine—Somnolence—Paclitaxel—lung cancer	0.00017	0.00121	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—lung cancer	0.00017	0.00121	CcSEcCtD
Pethidine—Nausea—Vinorelbine—lung cancer	0.000169	0.00121	CcSEcCtD
Pethidine—Asthenia—Irinotecan—lung cancer	0.000168	0.0012	CcSEcCtD
Pethidine—Constipation—Etoposide—lung cancer	0.000167	0.00119	CcSEcCtD
Pethidine—Decreased appetite—Paclitaxel—lung cancer	0.000166	0.00119	CcSEcCtD
Pethidine—Dry mouth—Docetaxel—lung cancer	0.000165	0.00118	CcSEcCtD
Pethidine—Asthenia—Gemcitabine—lung cancer	0.000164	0.00117	CcSEcCtD
Pethidine—Constipation—Paclitaxel—lung cancer	0.000164	0.00117	CcSEcCtD
Pethidine—Confusional state—Docetaxel—lung cancer	0.000163	0.00117	CcSEcCtD
Pethidine—Oedema—Docetaxel—lung cancer	0.000162	0.00116	CcSEcCtD
Pethidine—Anaphylactic shock—Docetaxel—lung cancer	0.000162	0.00116	CcSEcCtD
Pethidine—Pruritus—Gemcitabine—lung cancer	0.000162	0.00115	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—lung cancer	0.000161	0.00115	CcSEcCtD
Pethidine—Shock—Docetaxel—lung cancer	0.000159	0.00114	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—lung cancer	0.000159	0.00113	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—lung cancer	0.000158	0.00113	CcSEcCtD
Pethidine—Tachycardia—Docetaxel—lung cancer	0.000158	0.00113	CcSEcCtD
Pethidine—Feeling abnormal—Paclitaxel—lung cancer	0.000158	0.00113	CcSEcCtD
Pethidine—Hypersensitivity—Cisplatin—lung cancer	0.000157	0.00112	CcSEcCtD
Pethidine—Dizziness—Irinotecan—lung cancer	0.000155	0.00111	CcSEcCtD
Pethidine—Urticaria—Etoposide—lung cancer	0.000155	0.00111	CcSEcCtD
Pethidine—Anorexia—Docetaxel—lung cancer	0.000154	0.0011	CcSEcCtD
Pethidine—Asthenia—Cisplatin—lung cancer	0.000153	0.00109	CcSEcCtD
Pethidine—Sweating—Doxorubicin—lung cancer	0.000152	0.00109	CcSEcCtD
Pethidine—Urticaria—Paclitaxel—lung cancer	0.000152	0.00108	CcSEcCtD
Pethidine—Hypotension—Docetaxel—lung cancer	0.000151	0.00108	CcSEcCtD
Pethidine—Vomiting—Irinotecan—lung cancer	0.000149	0.00106	CcSEcCtD
Pethidine—Rash—Irinotecan—lung cancer	0.000148	0.00106	CcSEcCtD
Pethidine—Dermatitis—Irinotecan—lung cancer	0.000148	0.00105	CcSEcCtD
Pethidine—Headache—Irinotecan—lung cancer	0.000147	0.00105	CcSEcCtD
Pethidine—Insomnia—Docetaxel—lung cancer	0.000147	0.00105	CcSEcCtD
Pethidine—Vomiting—Gemcitabine—lung cancer	0.000145	0.00104	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—lung cancer	0.000145	0.00104	CcSEcCtD
Pethidine—Somnolence—Docetaxel—lung cancer	0.000144	0.00103	CcSEcCtD
Pethidine—Rash—Gemcitabine—lung cancer	0.000144	0.00103	CcSEcCtD
Pethidine—Dermatitis—Gemcitabine—lung cancer	0.000144	0.00103	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—lung cancer	0.000144	0.00103	CcSEcCtD
Pethidine—Erythema—Methotrexate—lung cancer	0.000143	0.00102	CcSEcCtD
Pethidine—Headache—Gemcitabine—lung cancer	0.000143	0.00102	CcSEcCtD
Pethidine—Decreased appetite—Docetaxel—lung cancer	0.000141	0.00101	CcSEcCtD
Pethidine—Hypersensitivity—Paclitaxel—lung cancer	0.000141	0.00101	CcSEcCtD
Pethidine—Asthenia—Etoposide—lung cancer	0.00014	0.000999	CcSEcCtD
Pethidine—Nausea—Irinotecan—lung cancer	0.000139	0.000995	CcSEcCtD
Pethidine—Constipation—Docetaxel—lung cancer	0.000139	0.00099	CcSEcCtD
Pethidine—Pruritus—Etoposide—lung cancer	0.000138	0.000985	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—lung cancer	0.000137	0.00098	CcSEcCtD
Pethidine—Asthenia—Paclitaxel—lung cancer	0.000137	0.00098	CcSEcCtD
Pethidine—Nausea—Gemcitabine—lung cancer	0.000136	0.000969	CcSEcCtD
Pethidine—Vomiting—Cisplatin—lung cancer	0.000135	0.000967	CcSEcCtD
Pethidine—Pruritus—Paclitaxel—lung cancer	0.000135	0.000966	CcSEcCtD
Pethidine—Rash—Cisplatin—lung cancer	0.000134	0.000959	CcSEcCtD
Pethidine—Dermatitis—Cisplatin—lung cancer	0.000134	0.000958	CcSEcCtD
Pethidine—Feeling abnormal—Docetaxel—lung cancer	0.000134	0.000954	CcSEcCtD
Pethidine—Flushing—Doxorubicin—lung cancer	0.000132	0.000944	CcSEcCtD
Pethidine—Dizziness—Etoposide—lung cancer	0.000129	0.000921	CcSEcCtD
Pethidine—Vertigo—Methotrexate—lung cancer	0.000129	0.000918	CcSEcCtD
Pethidine—Dizziness—Paclitaxel—lung cancer	0.000126	0.000903	CcSEcCtD
Pethidine—Nausea—Cisplatin—lung cancer	0.000126	0.000903	CcSEcCtD
Pethidine—Convulsion—Methotrexate—lung cancer	0.000124	0.000886	CcSEcCtD
Pethidine—Vomiting—Etoposide—lung cancer	0.000124	0.000886	CcSEcCtD
Pethidine—Erythema—Doxorubicin—lung cancer	0.000124	0.000885	CcSEcCtD
Pethidine—Rash—Etoposide—lung cancer	0.000123	0.000878	CcSEcCtD
Pethidine—Dermatitis—Etoposide—lung cancer	0.000123	0.000877	CcSEcCtD
Pethidine—Headache—Etoposide—lung cancer	0.000122	0.000873	CcSEcCtD
Pethidine—Vomiting—Paclitaxel—lung cancer	0.000122	0.000868	CcSEcCtD
Pethidine—Rash—Paclitaxel—lung cancer	0.000121	0.000861	CcSEcCtD
Pethidine—Dermatitis—Paclitaxel—lung cancer	0.00012	0.00086	CcSEcCtD
Pethidine—Headache—Paclitaxel—lung cancer	0.00012	0.000855	CcSEcCtD
Pethidine—Hypersensitivity—Docetaxel—lung cancer	0.000119	0.000853	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—lung cancer	0.000119	0.000851	CcSEcCtD
Pethidine—Confusional state—Methotrexate—lung cancer	0.000118	0.000841	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—lung cancer	0.000117	0.000834	CcSEcCtD
Pethidine—Asthenia—Docetaxel—lung cancer	0.000116	0.00083	CcSEcCtD
Pethidine—Nausea—Etoposide—lung cancer	0.000116	0.000827	CcSEcCtD
Pethidine—Pruritus—Docetaxel—lung cancer	0.000115	0.000819	CcSEcCtD
Pethidine—Agitation—Doxorubicin—lung cancer	0.000114	0.000813	CcSEcCtD
Pethidine—Nausea—Paclitaxel—lung cancer	0.000114	0.000811	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—lung cancer	0.000113	0.000806	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—lung cancer	0.000111	0.000795	CcSEcCtD
Pethidine—Anorexia—Methotrexate—lung cancer	0.000111	0.000795	CcSEcCtD
Pethidine—Syncope—Doxorubicin—lung cancer	0.000111	0.000794	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—lung cancer	0.00011	0.000782	CcSEcCtD
Pethidine—Hypotension—Methotrexate—lung cancer	0.000109	0.00078	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—lung cancer	0.000109	0.000778	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—lung cancer	0.000107	0.000767	CcSEcCtD
Pethidine—Dizziness—Docetaxel—lung cancer	0.000107	0.000765	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—lung cancer	0.000107	0.000764	CcSEcCtD
Pethidine—Insomnia—Methotrexate—lung cancer	0.000106	0.000755	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—lung cancer	0.000105	0.000751	CcSEcCtD
Pethidine—Somnolence—Methotrexate—lung cancer	0.000104	0.000742	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—lung cancer	0.000103	0.000737	CcSEcCtD
Pethidine—Vomiting—Docetaxel—lung cancer	0.000103	0.000736	CcSEcCtD
Pethidine—Rash—Docetaxel—lung cancer	0.000102	0.00073	CcSEcCtD
Pethidine—Dermatitis—Docetaxel—lung cancer	0.000102	0.000729	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—lung cancer	0.000102	0.000728	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—lung cancer	0.000102	0.000725	CcSEcCtD
Pethidine—Headache—Docetaxel—lung cancer	0.000102	0.000725	CcSEcCtD
Pethidine—Oedema—Doxorubicin—lung cancer	0.000101	0.000722	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—lung cancer	0.000101	0.000722	CcSEcCtD
Pethidine—Shock—Doxorubicin—lung cancer	9.95e-05	0.000711	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—lung cancer	9.87e-05	0.000705	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—lung cancer	9.78e-05	0.000698	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—lung cancer	9.64e-05	0.000689	CcSEcCtD
Pethidine—Nausea—Docetaxel—lung cancer	9.63e-05	0.000688	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—lung cancer	9.63e-05	0.000687	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—lung cancer	9.45e-05	0.000675	CcSEcCtD
Pethidine—Urticaria—Methotrexate—lung cancer	9.28e-05	0.000663	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—lung cancer	9.15e-05	0.000653	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—lung cancer	8.99e-05	0.000642	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—lung cancer	8.79e-05	0.000628	CcSEcCtD
Pethidine—Constipation—Doxorubicin—lung cancer	8.65e-05	0.000618	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—lung cancer	8.61e-05	0.000615	CcSEcCtD
Pethidine—Asthenia—Methotrexate—lung cancer	8.38e-05	0.000599	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—lung cancer	8.33e-05	0.000595	CcSEcCtD
Pethidine—Pruritus—Methotrexate—lung cancer	8.26e-05	0.00059	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—lung cancer	8.03e-05	0.000574	CcSEcCtD
Pethidine—Dizziness—Methotrexate—lung cancer	7.72e-05	0.000552	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—lung cancer	7.45e-05	0.000532	CcSEcCtD
Pethidine—Vomiting—Methotrexate—lung cancer	7.43e-05	0.00053	CcSEcCtD
Pethidine—Rash—Methotrexate—lung cancer	7.36e-05	0.000526	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—lung cancer	7.36e-05	0.000526	CcSEcCtD
Pethidine—Headache—Methotrexate—lung cancer	7.32e-05	0.000523	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—lung cancer	7.26e-05	0.000518	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—lung cancer	7.16e-05	0.000511	CcSEcCtD
Pethidine—Nausea—Methotrexate—lung cancer	6.94e-05	0.000496	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—lung cancer	6.69e-05	0.000478	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—lung cancer	6.43e-05	0.000459	CcSEcCtD
Pethidine—Rash—Doxorubicin—lung cancer	6.38e-05	0.000455	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—lung cancer	6.37e-05	0.000455	CcSEcCtD
Pethidine—Headache—Doxorubicin—lung cancer	6.34e-05	0.000453	CcSEcCtD
Pethidine—Nausea—Doxorubicin—lung cancer	6.01e-05	0.000429	CcSEcCtD
Pethidine—OPRM1—Signaling Pathways—FGFR1—lung cancer	7.74e-06	5.04e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.69e-06	5.01e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ENO1—lung cancer	7.65e-06	4.98e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2E1—lung cancer	7.64e-06	4.98e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HIF1A—lung cancer	7.62e-06	4.97e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.62e-06	4.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK3—lung cancer	7.61e-06	4.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—POMC—lung cancer	7.56e-06	4.93e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NQO1—lung cancer	7.56e-06	4.92e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.52e-06	4.9e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTT1—lung cancer	7.51e-06	4.89e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—lung cancer	7.49e-06	4.88e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—lung cancer	7.47e-06	4.87e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—lung cancer	7.46e-06	4.86e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—RRM1—lung cancer	7.44e-06	4.85e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA3—lung cancer	7.44e-06	4.85e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GCLC—lung cancer	7.42e-06	4.83e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2A6—lung cancer	7.42e-06	4.83e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.4e-06	4.82e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6R—lung cancer	7.38e-06	4.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CREBBP—lung cancer	7.37e-06	4.8e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOA1—lung cancer	7.36e-06	4.79e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.33e-06	4.78e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KDR—lung cancer	7.29e-06	4.75e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAT—lung cancer	7.28e-06	4.75e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—lung cancer	7.24e-06	4.72e-05	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.21e-06	4.69e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—lung cancer	7.09e-06	4.62e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ENO1—lung cancer	7.03e-06	4.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAP2K1—lung cancer	7.03e-06	4.58e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—B4GALT5—lung cancer	7e-06	4.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—lung cancer	6.99e-06	4.55e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TYMS—lung cancer	6.96e-06	4.53e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	6.92e-06	4.51e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—lung cancer	6.88e-06	4.48e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2E1—lung cancer	6.86e-06	4.47e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—lung cancer	6.84e-06	4.46e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—STK11—lung cancer	6.81e-06	4.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA4—lung cancer	6.81e-06	4.44e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NQO1—lung cancer	6.78e-06	4.42e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—lung cancer	6.72e-06	4.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APC—lung cancer	6.72e-06	4.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KIT—lung cancer	6.72e-06	4.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—lung cancer	6.72e-06	4.38e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EP300—lung cancer	6.7e-06	4.36e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.64e-06	4.33e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGF—lung cancer	6.64e-06	4.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA2—lung cancer	6.64e-06	4.32e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.58e-06	4.29e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP1A1—lung cancer	6.52e-06	4.25e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—lung cancer	6.51e-06	4.24e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ERCC2—lung cancer	6.47e-06	4.21e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—lung cancer	6.43e-06	4.19e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTA1—lung cancer	6.4e-06	4.17e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.39e-06	4.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—POMC—lung cancer	6.39e-06	4.16e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—lung cancer	6.34e-06	4.13e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCC3—lung cancer	6.33e-06	4.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—lung cancer	6.31e-06	4.11e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2E1—lung cancer	6.31e-06	4.11e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—lung cancer	6.3e-06	4.11e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	6.28e-06	4.09e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—lung cancer	6.27e-06	4.08e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—lung cancer	6.26e-06	4.08e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NQO1—lung cancer	6.24e-06	4.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RAF1—lung cancer	6.24e-06	4.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6R—lung cancer	6.24e-06	4.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CREBBP—lung cancer	6.23e-06	4.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—lung cancer	6.17e-06	4.02e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAT—lung cancer	6.13e-06	4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKR1C1—lung cancer	6.13e-06	3.99e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—lung cancer	6.12e-06	3.99e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—STK11—lung cancer	6.11e-06	3.98e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.1e-06	3.97e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—lung cancer	6.09e-06	3.97e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MTOR—lung cancer	6.09e-06	3.97e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—lung cancer	6e-06	3.91e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—lung cancer	5.97e-06	3.89e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—UGT1A1—lung cancer	5.95e-06	3.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAP2K1—lung cancer	5.94e-06	3.87e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—lung cancer	5.9e-06	3.85e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMS—lung cancer	5.86e-06	3.82e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—lung cancer	5.85e-06	3.81e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	5.85e-06	3.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—lung cancer	5.81e-06	3.79e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—lung cancer	5.79e-06	3.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—lung cancer	5.78e-06	3.77e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.74e-06	3.74e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNG11—lung cancer	5.74e-06	3.74e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—lung cancer	5.66e-06	3.69e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—lung cancer	5.65e-06	3.68e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—STK11—lung cancer	5.62e-06	3.66e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—lung cancer	5.6e-06	3.65e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOA1—lung cancer	5.6e-06	3.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—lung cancer	5.59e-06	3.64e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—lung cancer	5.56e-06	3.62e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAT—lung cancer	5.5e-06	3.59e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP1A1—lung cancer	5.49e-06	3.58e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.47e-06	3.57e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALDOA—lung cancer	5.46e-06	3.56e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—lung cancer	5.45e-06	3.55e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ERCC2—lung cancer	5.44e-06	3.55e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—lung cancer	5.44e-06	3.54e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—lung cancer	5.39e-06	3.51e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—lung cancer	5.36e-06	3.49e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	5.31e-06	3.46e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA3—lung cancer	5.3e-06	3.46e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—lung cancer	5.29e-06	3.45e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—lung cancer	5.29e-06	3.45e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—lung cancer	5.27e-06	3.44e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RAF1—lung cancer	5.27e-06	3.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—lung cancer	5.26e-06	3.43e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMS—lung cancer	5.26e-06	3.43e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—lung cancer	5.21e-06	3.4e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—lung cancer	5.2e-06	3.39e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—lung cancer	5.2e-06	3.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCG2—lung cancer	5.16e-06	3.36e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ADCY1—lung cancer	5.16e-06	3.36e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MTOR—lung cancer	5.15e-06	3.35e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—lung cancer	5.15e-06	3.35e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—lung cancer	5.13e-06	3.34e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—lung cancer	5.11e-06	3.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAT—lung cancer	5.06e-06	3.3e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPGDS—lung cancer	5.06e-06	3.3e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO2—lung cancer	5.06e-06	3.3e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.03e-06	3.28e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EP300—lung cancer	5.02e-06	3.27e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—lung cancer	4.95e-06	3.23e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—lung cancer	4.95e-06	3.22e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP1A1—lung cancer	4.93e-06	3.21e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—lung cancer	4.93e-06	3.21e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—lung cancer	4.91e-06	3.2e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—lung cancer	4.91e-06	3.2e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ERCC2—lung cancer	4.89e-06	3.18e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—lung cancer	4.88e-06	3.18e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—POMC—lung cancer	4.86e-06	3.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2A6—lung cancer	4.85e-06	3.16e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GCLC—lung cancer	4.85e-06	3.16e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMS—lung cancer	4.84e-06	3.15e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—lung cancer	4.79e-06	3.12e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—lung cancer	4.78e-06	3.12e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—lung cancer	4.78e-06	3.11e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—lung cancer	4.75e-06	3.1e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CREBBP—lung cancer	4.74e-06	3.09e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—lung cancer	4.73e-06	3.08e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—lung cancer	4.73e-06	3.08e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOA1—lung cancer	4.71e-06	3.07e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—lung cancer	4.71e-06	3.07e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—lung cancer	4.7e-06	3.06e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—lung cancer	4.69e-06	3.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—lung cancer	4.61e-06	3e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO1—lung cancer	4.6e-06	3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—lung cancer	4.6e-06	3e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—lung cancer	4.58e-06	2.99e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP1A1—lung cancer	4.53e-06	2.95e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.51e-06	2.94e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ERCC2—lung cancer	4.5e-06	2.93e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—lung cancer	4.5e-06	2.93e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—lung cancer	4.49e-06	2.93e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—lung cancer	4.47e-06	2.91e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—lung cancer	4.46e-06	2.9e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—lung cancer	4.45e-06	2.9e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—lung cancer	4.43e-06	2.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—lung cancer	4.37e-06	2.85e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—lung cancer	4.34e-06	2.83e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—lung cancer	4.3e-06	2.8e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—lung cancer	4.28e-06	2.79e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EP300—lung cancer	4.24e-06	2.76e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOA1—lung cancer	4.23e-06	2.75e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2E1—lung cancer	4.13e-06	2.69e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—lung cancer	4.12e-06	2.69e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—POMC—lung cancer	4.09e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NQO1—lung cancer	4.08e-06	2.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.05e-06	2.64e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—lung cancer	4.05e-06	2.64e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—lung cancer	4.04e-06	2.63e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—lung cancer	4.02e-06	2.62e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CREBBP—lung cancer	3.99e-06	2.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—lung cancer	3.98e-06	2.59e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—lung cancer	3.97e-06	2.58e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—lung cancer	3.91e-06	2.55e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOA1—lung cancer	3.89e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—lung cancer	3.88e-06	2.53e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—lung cancer	3.86e-06	2.52e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—lung cancer	3.8e-06	2.48e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—lung cancer	3.78e-06	2.46e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—lung cancer	3.71e-06	2.42e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—lung cancer	3.7e-06	2.41e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—STK11—lung cancer	3.68e-06	2.4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—POMC—lung cancer	3.67e-06	2.39e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—lung cancer	3.61e-06	2.35e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—lung cancer	3.59e-06	2.34e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CREBBP—lung cancer	3.58e-06	2.33e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—lung cancer	3.55e-06	2.31e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—lung cancer	3.43e-06	2.24e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—lung cancer	3.41e-06	2.22e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—lung cancer	3.4e-06	2.22e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—lung cancer	3.39e-06	2.21e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—lung cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—POMC—lung cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—lung cancer	3.35e-06	2.18e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAT—lung cancer	3.31e-06	2.16e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—lung cancer	3.29e-06	2.15e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CREBBP—lung cancer	3.29e-06	2.14e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—lung cancer	3.29e-06	2.14e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—lung cancer	3.26e-06	2.13e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—EP300—lung cancer	3.23e-06	2.1e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—lung cancer	3.22e-06	2.1e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMS—lung cancer	3.16e-06	2.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—lung cancer	3.14e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—lung cancer	3.13e-06	2.04e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—lung cancer	3.12e-06	2.03e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—lung cancer	3.08e-06	2.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—lung cancer	3.03e-06	1.98e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—lung cancer	3.03e-06	1.98e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.96e-06	1.93e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.96e-06	1.93e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ERCC2—lung cancer	2.94e-06	1.92e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—lung cancer	2.93e-06	1.91e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—lung cancer	2.9e-06	1.89e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—lung cancer	2.85e-06	1.86e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—lung cancer	2.78e-06	1.81e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—lung cancer	2.72e-06	1.77e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—EP300—lung cancer	2.72e-06	1.77e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—lung cancer	2.7e-06	1.76e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—lung cancer	2.56e-06	1.67e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—lung cancer	2.56e-06	1.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOA1—lung cancer	2.54e-06	1.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—EP300—lung cancer	2.44e-06	1.59e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—lung cancer	2.39e-06	1.55e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—lung cancer	2.35e-06	1.53e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.32e-06	1.51e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—EP300—lung cancer	2.24e-06	1.46e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—POMC—lung cancer	2.21e-06	1.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CREBBP—lung cancer	2.15e-06	1.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.04e-06	1.33e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—lung cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—lung cancer	2.01e-06	1.31e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—lung cancer	1.95e-06	1.27e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.8e-06	1.17e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.78e-06	1.16e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—lung cancer	1.76e-06	1.15e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.66e-06	1.08e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—lung cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—lung cancer	1.54e-06	1e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—lung cancer	1.47e-06	9.6e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—EP300—lung cancer	1.47e-06	9.55e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—lung cancer	1.35e-06	8.83e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.08e-06	7.06e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—lung cancer	8.86e-07	5.77e-06	CbGpPWpGaD
